Carbon Sources Attribute to Pathogenicity in Candida albicans by Sandai, Doblin et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 3
Carbon Sources Attribute to Pathogenicity in Candida
albicans
Doblin Sandai, Yasser Tabana and Rosline Sandai
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/intechopen.80211
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons 
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, 
distribution, and reproduction in any medium, provided the original work is properly cited. 
li   i, r    sli   i
dditional infor ation is available at the end of the chapter
Abstract
This topic was to examine the impact of galactose or fructose upon the assimilation of 
secondary carbon sources by Candida albicans. C. albicans ICL1 gene is repressed upon 
addition of 2% galactose or fructose to lactate- and oleic acid-grown cells. Further stud-
ies on CaFOX2, CaFBP1 and CaMLS1 transcripts in response to galactose or fructose on 
assimilation of lactate and oleic acid resulted in repression of these genes. The CaICL1 
gene, which encode the glyoxylate cycles enzymes isocitrate lyase are required for growth 
on non-fermentable carbon sources. However, the enzyme CaIcl1 was not destabilized 
by galactose, but was degraded in response to fructose. In contrast, S. cerevisiae Icl1 has 
retained the molecular apparatus of protein degradation in response to either galactose or 
fructose. Screening of ubiquitination site by http://www.ubpred.org/ showed that C. albi-
cans lacks ubiquitination site in gluconeogenic and glyoxylate cycles enzymes as compare 
to S. cerevisiae. Addition of a putative S. cerevisiae ubiquitination site carboxy terminus 
of CaIcl1 led to galactose- accelerated degradation of this protein in C. albicans cell via a 
ubiquitin-dependent process. In the other hand, CaIcl prior to addition of ubiquitination 
site was degraded upon exposure to fructose; addition of S. cerevisiae ubiquitination site 
to CaIcl1 further increased the speed of protein degradation.
Keywords: Candida albicans, galactose, fructose, glyoxylate cycles, isocitrate lyase, 
gluconeogenic, metabolic adaptation, protein degradation, ubiquitination
1. Introduction
Candida albicans is eukaryotic diploid (2N) sexual yeasts of the kingdom fungi [1]. C. albicans can 
divide asexually or can undergo parasexual reproduction, heterothallic or homothallic mating 
[2]. C. albicans genome sequencing project revealed the presence of sequences homologous to 
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the Saccharomyces cerevisiae MAT (mating type) loci, C. albicans MTL (mating-type-like) loci [3]. 
Members of the genus Candida are very heterogeneous, can grow in at least three different mor-
phologies; yeast, pseudo-hyphae and hyphae, such as C. albicans and C. dubliniensis [4, 5]. Further 
morphological forms exist during colony switching, such as white-opaque switching system 
involves switch between white domed colonies and opaque flat colonies [6], mating type-like 
locus a (MTLa) and MTLα cells must switch from white to opaque to become mating-competent 
[7]. Opaque cells secreted pheromones resulting in the formation of conjugation tubes, and sub-
sequently, cell and nuclear fusion occur to form tetraploid (4N) cells. Mating products can be 
induced to undergo concerted chromosome loss to return to the diploid state [8, 9].
In order to proliferate in a wide range of environmental niches, pathogens must not only 
depend on certain virulence factors, it is also important to have a flexible metabolism; there-
fore, they can assimilate a variety of carbon sources that are scarce or the only available carbon 
source at a specific environmental niche. The primary and preferred sources of metabolic 
carbon for most organisms are carbohydrates; it is used for generating energy and producing 
biomolecules. Before entering the glycolytic pathway, most sugars are converted to fructose-
6-phosphate or glucose-6-phosphate. ATP and NADH are produced from the conversion of 
hexose phosphates into the key metabolite pyruvate in glycolysis pathway. From there, two 
major strategies of energy production (fermentation and respiration) are carried out by cells. 
Although NAD+ is regenerated by both processes, respiration is more efficient than fermenta-
tion as it produces additional ATP through the oxidative phosphorylation and tricarboxylic 
acid (TCA) cycle. Glycolysis is the central, common pathway for both processes and it is criti-
cal for carbon assimilation; the pathway has been shown to be up-regulated during infections 
and important to the virulence in pathogenic bacteria, parasites, and fungi [10–12]. Glycolysis, 
gluconeogenesis, and the glyoxylate cycle are part of C. albicans central metabolism.
Central metabolic pathway such as glycolysis is strictly regulated, transcript of glycolytic 
enzymes is regulated in response to environmental conditions such as carbon source and avail-
ability, oxygen levels, and to cellular demands such as energy needs and metabolite concen-
trations. However, the regulators of glycolytic gene expression in most species have not been 
identified; for eukaryotes understanding of transcriptional control of glycolysis is mainly based 
on the non-pathogenic yeast Saccharomyces cerevisiae [13]. The transcription regulators (Gcr1 and 
Gcr2) are responsible for inducing the expression of the glycolytic genes in S. cerevisiae [14, 15], 
Gcr1p binds to CT boxes (5′-CTTCC-3′ ) upstream of the glycolytic genes and Gcr2p acts as a 
co-activator by forming a complex with Gcr1p [16]. Inactivation of either gene (GCR1 and GCR2) 
result in growth defects during culture on glucose, due to the decreasing expression levels of the 
glycolytic genes [15]. However, on non-fermentable carbon sources, the mutant strains display 
wild type growth rates [17]. Another glycolysis-specific regulator in S. cerevisiae is Tye7 (also 
known as Sgc1); it is involved in the activation of several glycolytic genes, although not to the 
extent of Gcr1 and Gcr2, this activation is independent of GCR1. No growth defects under any 
carbon source regime are detected in tye7 mutant strain [18].
C. albicans is an opportunistic fungus that is capable of metabolizing carbon sources through res-
piration and fermentation pathway similar to that of a typical eukaryotic cell. The culprit for more 
than half of all Candida infections is C. albicans [19]; this shows the importance of studying the 
metabolism of this pathogen for the development of effective antifungal treatments. C. albicans 
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is a Crabtree-negative organism that lacks GCR1/2 homologs and must control transcription of 
glycolytic genes differently as compared to S. cerevisiae. Tye7 and Gal4 are identified as two fungal-
specific activators of the glycolytic pathway in C. albicans, severe growth defects were observed 
in the mutant strains (tye7 and gal4) cultured on fermentable carbon sources when respiration 
was inhibited or oxygen was limited. Furthermore, chromatin immunoprecipitation coupled 
with microarray analysis (ChIP-CHIP) and transcription profiling showed these factors bind to 
and regulate expression of the glycolytic pathway genes. C. albicans mutant strains (tye7 and gal4) 
showed attenuated virulence in Galleria mellonella infection model, therefore TYE7 and GAL4 genes 
are required for pathogenicity and virulence of C. albicans [20].
Gluconeogenesis is required for yeast cells to generate sugar phosphates for the synthesis of 
essential cellular components, during the growth on non-fermentable carbon sources. Under 
physiological conditions with two exceptions, most of the glycolytic reactions are reversible. In 
many yeasts including S. cerevisiae and C. albicans, due to unfavorable thermodynamic balances, 
pyruvate kinase and phosphofructokinase have to be bypassed, this is achieved by phosphoenol-
pyruvate carboxykinase (Pck1, building phosphoenolpyruvate), and fructose-1,6-bisphosphatase 
(Fbp1, building fructose-6-phosphate). The enzymes of the glyoxylate cycle are necessary for 
gluconeogenesis, such as malate synthase (MLS) and isocitrate lyase (ICL). Moreover, in S. cerevi-
siae, in other to replenish TCA cycle intermediate (anaplerotic reactions), the succinate/fumarate 
transporter, Acr1p, has been shown to be a link between the glyoxylate cycle and the TCA cycle 
[21]. Not much is known about gluconeogenesis in C. albicans, whereas carbon sources/sugar 
phosphate may become available during lymphatic and blood infection, on skin after incorpora-
tion in macrophage, gluconeogenesis and the glyoxylate cycle may be depended for providing 
carbohydrates for cell wall biosynthesis [22].
The glyoxylate cycle is a “modified tricarboxylic acid (TCA) cycle,” instead of the two decar-
boxylation steps of the TCA cycle the key enzymes of the glyoxylate cycle (isocitrate lyase, 
ICL1 and malate synthase, MLS1) convert isocitrate and Acetyl-CoA into succinate and malate. 
ICL1 splits the isocitrate, C
6
-unit into succinate and glyoxylate, which in turn is condensed by 
malate synthase, MLS1 with Acetyl-CoA generating free CoA-SH and malate. Malate is then 
processed malate dehydrogenase to continue the cycle and succinate is released as net product, 
which can be used to replenish the TCA cycle or to function as precursors for carbohydrate 
biosynthesis or amino acid biosynthesis. C
4
-units (succinate) are generated by converting two 
Acetyl-CoA units generated by various catabolic processes. Therefore, the glyoxylate cycle 
enable cells to utilize fatty acids or C
2
-units such as ethanol or acetate as sole carbon source [23].
Fatty acids are broken down in the mitochondria by catabolic process (beta oxidation) to gen-
erate two-carbon units (Acetyl-CoA), which can be oxidized to CO
2
 and H
2
O via the TCA cycle 
or used to generate hexose via the glyoxylate and gluconeogenesis, and NADH and FADH
2
, 
which are co-enzymes used in electron transport chain. In yeast S. cerevisiae, β-oxidation and 
peroxisome biogenesis are regulated by transcription factors, OAF1 and PIP2. However, such 
homolog is not present in C. albicans. Instead, C. albicans share a single homolog of transcrip-
tion factors FarA/FarB with A. nidulans, CTF1 which regulate genes for β-oxidation enzymes, 
glyoxylate cycle, and the gluconeogenesis in the presence of fatty acids. CTF1 is important 
for growth on fatty acids and regulation of several genes encoding enzymes associated with 
β-oxidation, including FOX2. Deletion of FOX2 (fox2Δ/fox2Δ (fox2Δ/Δ) strains) confers a mild 
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attenuation of virulence [24, 25]. Therefore, C. albicans appears to share more similarity to that 
of filamentous fungi than to that of budding yeast at phenotypic and genotypic level in the 
regulation of alternative carbon assimilation pathways, but there are clearly Candida-specific 
adaptations in these regulatory networks [26].
Glyoxylate cycle is present in fungi but not in mammals, and β-oxidation of fatty acids develop 
in different directions between mammals and fungi. Therefore, in order to have a better under-
stand on the importance of these pathways, physiological and virulence of mutant strains 
lacking of these genes encoding key enzymes the β-oxidation multifunctional protein (FOX2), 
glyoxylate cycle (isocitrate lyase, ICL1), and gluconeogenesis (fructose-1,6-bisphosphatase, 
FBP1) was studied. Deletion of ICL1 or FOX2 or FBP1 confers attenuation to some degree 
in a mouse model of disseminated candidiasis. Therefore, confirming that alternative carbon 
sources are relevant nutrients in vivo, and C. albicans probably consume multiple carbon 
sources during infection. Finally, in vitro genomic and phenotypes analysis indicate that the 
regulatory networks that control alternative carbon metabolism in S. cerevisiae differ signifi-
cantly from the paradigms developed in C. albicans [25, 27].
In the present of glucose, C. albicans undergoes yeast-to-hyphal transition which is crucial for 
virulence and invasion of host cells [28]. The hyphal form can diffuse through the tissues or 
form mycelial biofilms, and the yeast form is thought to disseminate easily via body fluids [29]. 
Glucose is an important carbon sources in central metabolism pathway, thus glucose sensing 
and response is closely regulated and highly evolved in most organisms. For example, C. albicans 
appears to have over 20 different hexose transporters that are expressed under different condi-
tions and S. cerevisiae has at least 17 [30], it is presumed that this large number of hexose transport-
ers is required because S. cerevisiae prefers to ferment glucose. S. cerevisiae demands a high influx 
of glucose because for each molecule of glucose metabolized, it yields only two molecules of 
ATP. In contrast, C. albicans also has many hexose transporters although it is presumed to prefer 
respiration and thus can yield up to 38 ATPs per glucose molecule metabolized [31]. This might 
be the reason why C. albicans can thrives in various niches, which likely release many different 
sugars as carbon sources.
Not much is known about how C. albicans senses and responds to sugars, therefore S. cerevi-
siae a paradigm for non-conventional yeasts is used as a model to elucidate sugar-sensing and 
signaling pathway that primarily regulates glucose transport. In yeast S. cerevisiae, glucose is 
detected by two glucose sensors in the cell membrane, which are Snf3 and Rgt2. The glucose 
sensors are orthologs of transporters with long cytoplasmic tails for intracellular signaling, 
which are missing from glucose transporters. The sensors cannot transport sugar but they 
control sugar acquisition by regulating the expression of genes encoding hexose transporters 
(HXTs) [32]. A single point mutation in the S. cerevisiae glucose sensors Snf3 (R229K) or Rgt2 
(R231K) resulted in constitutive expression of genes encoding hexose transporters, because 
these mutations may convert the sensors into their glucose-bound (signaling) conformations 
[33]. C. albicans possesses glucose sensors, Hgt4 (orf19.5962) which is an ortholog of the Snf3 
and Rgt2, Hgt4 generates an intracellular signal to induce expression of certain HGT genes 
encoding hexose transporters which is required for growth on glucose, for optimal virulence, 
and for filamentation [34].
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Similar observation is observed between S. cerevisiae and C. albicans, ICL1 and PCK1, whereby 
upon exposure to 2% glucose the transcription from DNA to mRNA are repressed. However, 
in contrast to S. cerevisiae, Icl1 and Pck1, which are degraded rapidly upon exposure to glucose. 
C. albicans, Icl1 and Pck1 remain stable [35]. This suggests that C. albicans undergoes catabolite 
inactivation on transcriptional level but not on the protein degradation level, which further 
implicate that the proteins (Icl1 and Pck1) are subjected to post-translational modifications. Post-
translational modifications of proteins, such as acetylation, phosphorylation and ubiquitination, 
play important roles in generating and relaying signal in almost every cellular pathway as well 
as cellular adaptation of all organisms, which includes their growth, differentiation, division and 
development. These protein modifications are important for the regulation of the pre-existing 
proteins’ functions, activities and stabilities, thereby controlling dynamic cellular processes [36].
Similar to that in S. cerevisiae, C. albicans polyubiquitin is encoded by the UBI4 gene, which 
has three rather than five tandem repeats in a consecutive head-to-tail arrangement that 
is found in S. cerevisiae [37]. Decrease in the polyubiquitin encoded by the UBI4 gene in C. 
albicans induces the growth of hyphae and pseudohyphae [38]. This was compatible with 
previous studies indicating that the ubiquitination via the E2 enzyme, Rad6 inhibits hyphal 
development in C. albicans [39]. Furthermore, polyubiquitin is presumed to contribute to 
stress responses in C. albicans, because downregulation of UBI4 resulted in mild tempera-
ture sensitivity in stationary cells grown in glycerol, but not during growth on glucose [38]. 
Therefore, it has been implied that the UBI4 gene is necessary for viability in C. albicans [38]. 
For example, recent studies show that ubiquitination sites are present in glyoxylate cycle and 
gluconeogenesis enzymes from S. cerevisiae but absent from their C. albicans homologs [35]. 
This indicates that evolutionary rewiring of ubiquitination targets upon glucose exposure; 
this implies C. albicans proteins remain functional, allowing it to continue metabolize alterna-
tive carbon sources [35]. This metabolic flexibility is presumed to be important during infec-
tion and colonization of dynamic host niches with variable carbon sources.
Lorenz and Fink [27] have proved the importance of key enzyme, ICL1 of glyoxylate cycle to 
the virulence and pathogenicity of C. albicans. Deletion of the gene cause attenuated virulence 
in mice model. This highlights the importance of ICL1 as a factor that contributes to the viru-
lency and viability of C. albicans and provides a new target site for antifungal drugs test. For 
example, caffeic acid, rosmarinic acid, and apigenin were found to have antifungal activity 
against C. albicans ICL1 when tested under glucose-depleted conditions [40].
Thus, it is important to have a better understanding and studying the mechanism involved, 
and the fitness attribute of the key enzymes in central metabolism of C. albicans. Recent stud-
ies by Sandai et al. [35] indicate that glucose trigger degradation of transcript in C. albicans, 
ICL1 and PCK1 but not the protein. This suggests that C. albicans have undergone evolution-
ary rewiring and lacks ubiquitination site as compared to S. cerevisiae. As such, this study 
was mainly focused on the effects of galactose and fructose on the central metabolism of 
C. albicans. Galactose is metabolized to the more metabolically useful glucose-6-phosphate 
by the enzymes of the Leloir pathway. This pathway is necessary as the initial enzymes of 
glycolysis are unable to recognize galactose. Of all the sugars found in nature, only D-fructose 
feeds directly into glycolysis, the central pathway of carbohydrate metabolism.
Carbon Sources Attribute to Pathogenicity in Candida albicans
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2. Effect of galactose or fructose on C. albicans FOX2, FBP1, MLS1 
and ICL1 mRNAs
There are reports that state repression on transcriptome by glucose in S. cerevisiae [41]. For 
example, study by Yin et al. [42] using northern blotting and transcriptomic analyses showed 
that transcripts encoding the gluconeogenic enzymes (FBP1 and PCK1) are repressed by glu-
cose in S. cerevisiae. Furthermore, previous work by Sandai et al. [35] reported that ICL1 and 
PCK1 are repressed by glucose in C. albicans and S. cerevisiae. To reconfirm this report and 
to compare it with the galactose and fructose responses of C. albicans more directly in this 
study, we first examined the responses of S. cerevisiae glyoxylate cycle (ScICL and ScMLS1), 
β-oxidation (ScFOX2) and gluconeogenesis (ScFBP1) mRNAs using the following experi-
mental approach.
S. cerevisiae ICL1 mRNA levels showed a dramatic decrease within 1 hour of galactose or 
fructose addition to the cells growing on lactate or oleic acid. Similarly, ScFBP1, ScFOX2 and 
ScMLS1 mRNAs levels declined after galactose or fructose addition to the cells growing on 
lactate or oleic acid media. This strong repression occurred 1 hour after galactose or fructose 
addition. These confirmed that in S. cerevisiae, the ICL1, FBP1, FOX2 and MLS1 transcripts are 
strongly repressed by galactose and fructose [43].
Global transcriptional responses of C. albicans to low (0.01%), medium (0.1%) and high (1%) 
glucose concentrations by microarray analysis indicated that a total of 347 C. albicans gene were 
up-regulated and 344 genes were down-regulated in responses to at least one of the glucose con-
centration examined. There are 170 of these genes were up-regulated and 180 genes were down-
regulated by 0.01% glucose, indicating about half of glucose-regulated genes are responsive to 
low glucose levels [42]. Therefore, it is concluded that C. albicans and S. cerevisiae is acquisitively 
sensitive to glucose. Hence, at the start of this study, an aim was to confirm the impact of galac-
tose and fructose upon specific mRNAs that encode enzymes required for the assimilation of 
alternative carbon sources. The transcripts encoding the glyoxylate cycle enzyme isocitrate lyase 
(CaICL1), fructose-1,6-biphosphatase (CaFBP1), malate synthase (CaMLS1) and multifunctional 
enzyme of the peroxisomal fatty acid beta-oxidation pathway (CaFOX2) were the main focus here.
C. albicans cells were grown to mid-exponential phase in media containing lactate or oleic 
acid as the sole carbon source using the same procedures [35]. Galactose or fructose was then 
added to a final concentration of 2%, samples taken for RNA analysis at various times there-
after, and the levels of the CaICL1, CaFOX2, CaMLS1, CaFBP1 and CaACT1 mRNAs were 
measured. The relative expression of CaICL1, CaFBP1, CaFOX2 and CaMLS1 (compared to 
the internal CaACT1 control) was high in lactate- and oleic acid-grown cells compared to cells 
that were exposed to either galactose or fructose.
3. Role of ubiquitination in sugar phosphate-accelerated protein 
degradation in C. albicans
Research done by Sandai et al. [35] suggested that S. cerevisiae has retained the ability to 
degrade target proteins in response to glucose, but that C. albicans isocitrate lyase (ICL1) has 
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lost the specific signal(s) that trigger this glucose-accelerated protein degradation. However, 
studies have not been done on the effect of other sugar phosphate such as galactose or fruc-
tose, both are important carbon sources that are absorbed directly into the blood from intes-
tine. This studies focus on whether CaIcl1 protein has lost the specific signal that trigger 
protein degradation with the formation of ubiquitin-proteasome complex.
Ubiquitination play an important role in the glucose-accelerated degradation of gluconeogenic 
enzymes in S. cerevisiae [20] by acting as a degradation signal in S. cerevisiae [44]. This fact is 
supported by Eschrich et al. [22], in which ubc8 functions in the catabolite degradation of 
fructose-1,6-biphosphatase in S. cerevisiae. Therefore, consensus ubiquitination target sites 
were examined in CaIcl1 and ScIcl1, CaMls1 and ScMls1, CaFox2 and ScFox2, and CaFbp1 and 
ScFbp1 using ubpred (predictor of protein ubiquitination site, from http://www.ubpred.org/
index.html) [45, 46] (Figure 1).
Based on this bioinformatics comparison, the ScIcl sequence containing strong consensus 
ubiquitination sites at amino acid 158 and 551, but there is a lack of high confidence ubiq-
uitin target in CaIcl1, CaMls1, ScMls1, CaFbp1 and ScFbp1 (Figure 1). Interestingly, CaFox2 
contain one strong consensus ubiquitination site at amino acid 588, but there is none high 
confidence ubiquitination target in ScFox2. This prediction was based on high level of confi-
dence which is described in UbPred system containing score range 0.84 ≤ s ≤ 1.00, 0.197 for 
sensitivity and 0.989 for specificity. However, focus of this study is on Icl1 because it is more 
important for C. albicans virulency. Deletion of ICL1 gene in C. albicans attenuated virulence 
[27] while deletion of FOX2 confers mild attenuation of virulence of C. albicans [26].
Figure 1. Comparison of an amino acid pile-up of (A) CaMls1 and ScMls1. (B) CaFbp1 and ScFbp1. (C) CaFox2 and 
ScFox2. (D) CaIcl1 and ScIcl1. In which the high confidence ubiquitination sites are highlighted. (E) Compilation of high 
ubiquitination site in C. albicans and S. cerevisiae Icl1, Mls1, Fox2 and Fbp1.
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The bioinformatics screening of ubiquitination site includes the hydrophobic nature of the 
ubiquitination target site for high confidence prediction (TEDQFKENGVKK), which is contrast 
to the low and medium confidence sites which contain acidic and basic residues in the putative 
ubiquitination site (NGVKK; FNWPKAMSVD) [45, 46]. Therefore, the presence of consensus 
ubiquitination sites in these proteins correlated with glucose-accelerated degradation [35].
4. Overview of carbon sources attribute to the pathogenicity to  
C. albicans
The effect of galactose or fructose on the expression levels of the CaIcl protein in C. albicans 
and to compare this response with the corresponding situation in S. cerevisiae were tested. The 
effects of glucose on S. cerevisiae fructose-1,6-bisphosphatase (FBPase) have been intensively 
studied and it was reported that the FBPase protein (ScFbp1) is rapidly degraded upon addi-
tion of glucose [47]. It is also reported by Hammerle et al. [48] that the levels of cytosolic 
malate dehydrogenase, fructose-1,6-biphosphatase, isocitrate lyase and phosphoenolpyru-
vate carboxykinase are all low in S. cerevisiae after glucose addition. However, the degrada-
tion of FBPase is not correlated with the prediction of ubiquitination target site presence in 
the protein as ScFbp1 has only one low confidence ubiquitination target site at amino acid 
250 (Figure 1B). The reason is not known whether or not FBPase had undergone ubiquitin-
proteasome machinery although Regelmann et al. [49] have found that there are two different 
degradation pathways: cytosolic ubiquitin-proteasome machinery, and the other dependent 
on vacuolar proteolysis. Genes that are essential for vacuolar degradation are unnecessary for 
proteasome-dependent degradation [49].
Therefore, as a starting point whether Icl1 decline in S. cerevisiae upon galactose or fructose 
addition. To achieve this, the S. cerevisiae which is tagged at its 3′-end with Myc
9
 is obtained 
from Sandai et al. [35]. Cells were grown on lactate, and then subjected to 2% of galactose or 
fructose. Samples were harvested at various times point and the Icl1 proteins expression was 
determined by western blotting and normalized by beta Actin. Clearly galactose or fructose 
addition led to the degradation of ScIcl1. These results confirmed that in S. cerevisiae, Icl1 are 
degraded in response to galactose or fructose. Similar results are observed in study done by 
Sandai et al. [35], whereby ScIcl1 and ScPck1 are degraded in response to glucose.
Next was to determine the effect of galactose or fructose addition to C. albicans cell growing 
on lactate. C. albicans strains expressing Myc
3
-tagged Icl1 was confirmed by western blot-
ting. C. albicans cells were grown in media containing the non-fermentable carbon sources 
lactate as sole carbon sources and the 2% galactose or fructose was added while cells were in 
exponential phase. Cells were then harvested at various times, and their proteins extracted 
and were loaded equally onto the SDS-PAGE gels, and expression of the Myc
3
-tagged CaIcl1 
protein is detected with anti-Myc antibodies and normalized by beta-actin. The C. albicans Icl1 
protein was expressed during growth on lactate and was not destabilized by the addition of 
2% galactose. Indeed CaIcl1 proteins levels were not significantly different from the control 
(lactate) even after 4 hours. Likewise, similar result was obtained by Sandai et al. [35] in which 
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CaIcl1 proteins remained stable after addition of 2% glucose to lactate grown cells. However, 
interestingly CaIcl1 protein is destabilized after addition of 2% fructose to lactate grown cells. 
This result contradicts the finding that CaIcl1 has lost the specific signal(s) that trigger protein 
degradation. This might prove the points by Regelmann et al. [49] that except from ubiquitin 
proteasome pathways the protein can undergo degradation through vacuolar proteolysis. 
However, the exact mechanism of why fructose triggers such pathway is not known.
Testing was carried out to see whether C. albicans is able to degrade proteins in response to 
galactose or fructose, the S. cerevisiae ICL1 gene is expressed in C. albicans. C. albicans ICL1 
allele was replaced with a tagged S. cerevisiae ICL1. Ca(ScIcl1-Myc
3
) was then grown in lac-
tate before subjected to 2% galactose or fructose. Western blot was performed to confirm the 
expression of the Myc
3
-tagged ScIcl1 which will be normalized to housekeeping protein beta-
actin. From the results, ScIcl1 protein expression remained stable in C. albicans cells grown on 
lactate. However, following addition of 2% galactose or fructose to C. albicans cells, ScIcl1 was 
degraded. This indicates that C. albicans has retained capacity to destabilize target proteins in 
response to galactose or fructose. In other words, ScIcl1 retained its molecular apparatus for 
protein degradation even if it is expressed in C. albicans cells.
Testing was also carried out to determine whether C. albicans Icl1 expression remains stable 
in response to galactose or fructose, the C. albicans ICL1 gene was expressed in S. cerevisiae. 
S. cerevisiae ICL1 allele was replaced with a tagged C. albicans ICL1. Sc(CaIcl1-Myc
3
) was then 
grown in lactate before subjected to 2% galactose or fructose. Cells were harvested at different 
time points thereafter and western blot was performed to confirm the expression of the Myc
3
-
tagged CaIcl1 which is normalized to beta-actin. From the results, CaIcl1 protein expression 
remained stable in S. cerevisiae cells grown on lactate. However, following addition of 2% 
fructose to S. cerevisiae cells, CaIcl1 was degraded. This supports the previous result that C. 
albicans Icl1 although lacks ubiquitination site but is sensitive to fructose and might undergo 
a different proteolysis. C. albicans has lost capacity to destabilize target proteins in response 
to 2% galactose. In other words, CaIcl1 was not degraded and remained stable in S. cerevisiae.
S. cerevisiae Icl1 has two high confidence putative ubiquitination sites located at residues 551 
and 158, whereas CaIcl1 has no such sites (Figure 1). Therefore, ubiquitination plays a role in 
glucose-accelerated protein decay in C. albicans; the addition of a ubiquitination site to CaIcl1 
would confer glucose-accelerated degradation upon this protein Sandai et al. [35]. Therefore 
carboxy-terminal ubiquitin site from ScIcl (TEDQFKENGVKK) was added into CaIcl1, together 
with the Myc
3
 tag into the wild type polyubiquitin containing C. albicans cells. The function of 
ubiquitination in regulation rewiring of C. albicans Icl1 in response to galactose or fructose was 
tested. Cells were grown in lactate and galactose or fructose was added to final concentration 
of 2%. Cells were harvested at different time points thereafter, protein extracted and quanti-
fied, and these subjected to western blotting. The CaIcl-Ubi-Myc
3
 proteins are normalized to 
housekeeping protein beta-actin. The result obtained shows that CaIcl-Ubi-Myc
3
 is degraded 
upon addition of galactose or fructose to non-fermentable carbon sources, lactate. The results 
confirm a finding in a research done by Sandai et al. [35] whereby additions of glucose to lac-
tate grown DSCO4 cells degrade the protein. This has also proven that ubiquitination plays a 
significant role in regulation of central metabolism enzymes in both C. albicans and S. cerevisiae.
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5. Conclusion and future perspective
The assimilation of carbon sources is fundamentally important for the growth of C. albicans 
and for the establishment of infections in the human host [10]. For most yeast, such as S. cerevi-
siae, glucose is generally a more favorable carbon sources and the chosen mode of metabolism 
is often fermentative via glycolytic pathway-Embden-Meyerhof fermentation. In the presence 
of excess glucose, S. cerevisiae utilize glycolytic pathways and produce ethanol. S. cerevisiae 
is Crab-negative yeast that has the ability to produce ethanol even in the absence of oxygen 
[50]. In contrast, C. albicans is Crab-positive yeast because it retains respiratory capacity in the 
presence of excess glucose [51].
C. albicans is glucose Crabtree positive yeast which retains respiratory activity even following 
exposure to glucose [51]. During growth on glucose, ADH1 mRNA levels rise to maximum 
levels during late exponential growth phase and the decline to low levels in stationary phase 
[52]. The ADH1 mRNA is relatively abundant during growth on galactose, glycerol, pyruvate, 
lactate or succinate, and less abundant during growth on glucose or ethanol. However, alco-
hol dehydrogenase levels do not correlate closely with ADH1 mRNA levels. This locus may 
be controlled in both transcriptional and post-transcriptional levels, or other differentially 
regulated ADH loci may exist in C. albicans [51]. Interestingly, a significantly smaller propor-
tion of glucose is fermented to ethanol by C. albicans than by S. cerevisiae [51].
S. cerevisiae is not able to assimilate both non-fermentable carbon sources and galactose/
fructose at the same time because of repression. Hence, these yeasts have evolved different 
responses to galactose/fructose. Therefore in this analysis was done on regulation of carbon 
assimilation in C. albicans focusing on genes/enzymes involved in gluconeogenesis, glyoxyl-
ate cycle and β-oxidation. ICL1, FOX2, MLS1, and FBP1 gene expression and the impact of 
galactose or fructose on the assimilation of non-fermentable carbon sources were analyzed. 
C. albicans responses were then compared to those of S. cerevisiae under equivalent conditions. 
The following conclusions can be drawn from these findings;
First, gluconeogenic, glyoxylate cycle and β-oxidation mRNAs are sensitive to galactose or 
fructose in both C. albicans and S. cerevisiae. This reconfirmed previous finding, whereby the 
transcriptome, such as PCK1 and FBP1 in S. cerevisiae [42], ICL1 and PCK1 in both S. cerevisiae 
and C. albicans [35], was degraded upon exposure to glucose. The dramatic decreases in ICL, 
MLS1, FOX2 and FBP1 mRNA levels in C. albicans after exposure to 2% galactose or fructose 
to lactate- and oleic acid-grown cells was observed. It is already known that C. albicans sensi-
tive to glucose concentrations even as low as 0.01%, this value is within the physiological 
range of blood glucose (about 0.1%) [10, 12]. Therefore, C. albicans is able to respond to blood 
glucose levels during disseminated hematological infections. Interestingly, diabetic patients 
who often have elevated blood glucose levels have a higher risk of systemic Candida infections 
[53] and dietary glucose enhances C. albicans colonization and invasion [54]. Galactose and 
fructose are both important sugar phosphate to human and yeast. Galactose can be converted 
to glucose through Leloir pathway which utilized three enzymes in human liver [55] and five 
enzymes in yeast [56]. In mammary gland galactose covalently bound to glucose to formed 
disaccharide lactose [57]. Moreover individual with galactosemia, a rare inherited metabolic 
disorder that affects the body ability to metabolize galactose properly and have high content 
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of galactose in both urine and blood. This increases the risk of developing E. coli sepsis and 
sometimes or rarely fungal sepsis, such as Candida species [58].
Second main observation was that the Icl1 proteins are stable in C. albicans following galac-
tose exposure but not fructose. The addition of 2% galactose to C. albicans cells growing on 
lactate did not trigger the degradation of the Icl1 proteins, but the protein was degraded 
upon addition of 2% fructose, at least 4 hours examined. This is in contrast to the situation 
in S. cerevisiae, where the addition of 2% galactose or fructose triggered the rapid degrada-
tion of the Icl1 proteins. The estimated half-lives for these proteins in S. cerevisiae are more 
than 20 hours [46] indicating that these proteins are very stable. This probably represents a 
significant difference in the physiological responses of these pathogenic and benign yeasts to 
glucose. C. albicans is able to establish infections in complex niches, many which contain a rich 
mixture of alternative carbon sources [10]. The stability of the Icl1 protein in C. albicans, even 
in the presence of galactose and glucose [35] might suggest that this pathogen is capable to 
assimilate alternative carbon sources at the same time as galactose or glucose in these carbon-
rich niches. The observation from addition of galactose and glucose is similar in C. albicans, 
this may be because galactose and glucose is reversibly convertible in Leloir pathway, and 
galactose is first converted to glucose to enter the glycolysis pathway.
Interestingly there is a finding that fructose increases phosphorylation/activation of hypo-
thalamic AMP kinase causing phosphorylation/inactivation of Acetyl-CoA carboxylase, 
whereas glucose has the inverse effects [59]. This finding is interesting because acetyl-coen-
zyme A (Acetyl-CoA) is an essential cofactor in central metabolism, this molecule is the entry 
point to the tricarboxylic acid (TCA) cycle that generates energy, biomass, and intermediates 
for macromolecules [59]. This means that addition of fructose might repressed Acetyl-CoA 
in C. albicans which will in turn affects the TCA and glyoxylate cycle. However, this might 
not be the only reason for Icl1 protein decay in C. albicans in response to fructose. Glucose 
enters the glycolytic pathway via glucokinase-catalyzed phosphorylation and its further 
metabolism is subjected to control in phosphofructokinase (PFK) in the glycolytic pathway, 
which is considered to be rate-limiting step. In contrast, fructose is metabolized faster than 
glucose because it bypasses this step entering the glycolytic pathway at the level of the 
triose phosphates. This showed that fructose is a much efficient carbon sources compared to 
glucose or alternative non fermentable carbon sources such as lactate.
The third observation whether C. albicans has lost signal that trigger destabilization in 
response to galactose and retained molecular capability of destabilizing target proteins in 
response to fructose. C. albicans ICL1 ORF was expressed in S. cerevisiae and vice versa S. cere-
visiae ICL1 ORF was expressed in C. albicans. The CaIcl1 in S. cerevisiae remained stable even 
after addition of 2% galactose but was degraded after addition of 2% fructose was tested. The 
finding supported the previous report. This is interesting because it proved that C. albicans 
Icl1 is sensitive to fructose but not to galactose. In contrast, ScIcl1 in C. albicans was degraded 
in response of 2% galactose or fructose.
The analysis of ubiquitination in C. albicans was done by exposing CaIcl1-Ubi-Myc
3
 to 
2% galactose or fructose. C. albicans Icl1 is destabilized by galactose because of the addi-
tion of carboxyl-terminal ubiquitination site. In previous finding the fructose destabilize 
CaIcl1 and addition of ubiquitin site accelerated the destabilization of the protein. Cells 
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can no longer able to metabolize via the glyoxylate cycle following galactose and fructose 
addition due to the degradation of Icl1 protein. As a result, those cells would presumably 
be less able to cause infections and would be less able to compete for available nutrients 
against other microorganisms such as endogenous bacteria in the gastrointestinal (GI) 
tract compared to their wild type. It is likely to show less successful colonization, virulence 
and fitness due to this defect in its ability to assimilate both glucose and alternative carbon 
sources at the same time. Similarly, mutant C. albicans cell with deletion of ICL1 attenuated 
virulence [27].
It is interesting to further study the mechanism involved in protein degradation in response to 
fructose. Why is only fructose and not glucose or galactose that triggers protein degradation 
of CaIcl1? And which pathways could CaIcl1 take for proteolysis? Is it vacuolar proteolysis 
or ubiquitin mediated proteolysis, such as ubiquitin conjugating enzyme Ubc8p [43] and E3 
ubiquitin ligase, Gid complex [49, 60]? It is also interesting to explore other central metabo-
lism enzymes that carry the same characteristic of CaIcl1 and also to determine the effect of 
exposure to other carbon sources such as malate and succinate.
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